Actively Recruiting
Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
Led by Tongji Hospital · Updated on 2026-06-04
800
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a prospective, observational study to build a clinical database for liver cancer diagnosis and treatment. The study focuses on collecting comprehensive diagnostic, treatment, and long-term outcome information from patients treated at the Department of Hepatobiliary and Pancreatic Surgery. This database will help evaluate prognosis and treatment effectiveness in real-world clinical practice, supporting better clinical decisions in the future. Participants are grouped based on their treatment approach, including those undergoing liver resection surgery and those receiving systemic therapy combined with locoregional interventions such as PD-1 inhibitors and targeted drugs. The study observes these treatments without assigning interventions, reflecting real-world patient care. Throughout the study, participants' overall survival is tracked from treatment until death from any cause, with assessments up to 100 months. Researchers also monitor adverse events within 30 days after treatments. Data collection includes full diagnostic and therapeutic details alongside long-term follow-up to understand treatment outcomes and safety. The study will run from January 2026 through December 2029.
CONDITIONS
Brief Title
Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 6518 years at the time of signing the informed consent form
- Clinically or histologically confirmed diagnosis of liver cancer
- Receiving treatment and follow-up in Tongji Hospital
You will not qualify if you...
- Refuse participating in this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 30 days following surgery
Participants in the liver resection group undergo surgery to remove liver tumors and receive immediate post-operative care.
Approximately 6 post-operative visits
Duration - Duration as per treatment plan
Participants in the non-surgery group receive systemic therapy with PD-1 inhibitors combined with targeted drugs and locoregional interventions.
Visit schedule according to treatment regimen
Duration - Up to 100 months
Participants are monitored for overall survival and adverse events following treatment.
Regular follow-up visits during monitoring period
Trial Site Locations
Total: 1 location
1
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030
Actively Recruiting
Research Team
Q
Qi Cheng, M.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here